As per the latest market research conducted by FMI, the global microneedle drug delivery systems market is expected to record a CAGR of 6.6% from 2023 to 2033. In 2023, the market size is projected to reach a valuation of US$ 768.9 million. By 2033, the valuation is anticipated to reach US$ 1459.1 million.
In order to administer enough doses of medication to have the desired therapeutic effect, hundreds of microneedles are arranged in arrays on a small patch. As a result, there is now a direct route for a medication to enter the viable epidermis without coming into contact with the nerves and blood vessels found in the dermal layers. Depending on their qualities, numerous types of materials, including ceramic, silicon, silica glass, carbohydrates, and polymers, are utilized to make microneedles, thus driving the microneedling tool market in the coming years. Typically, microneedles measure hundreds of microns in length, 1 to 50 micrometers in width at the tip, and 50 to 300 micrometers in length at the base.
Significant Market Trends:
| Attributes | Value |
|---|---|
| Microneedle Drug Delivery Systems Value (2022) | US$ 722.2 million |
| Microneedle Drug Delivery Systems Market Expected Value (2023) | US$ 768.9 million |
| Microneedle Drug Delivery Systems Market Forecast Value (2033) | US$ 1459.1 million |
| Microneedle Drug Delivery Systems Market Expected CAGR (2023 to 2033) | 6.6% |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Principal Consultant
| Particulars | Details |
|---|---|
| H1, 2021 | 6.46% |
| H1, 2022 Projected | 6.60% |
| H1, 2022 Outlook | 6.10% |
| BPS Change - H1, 2022 (O) - H1, 2022 (P) | (-) 50 ↓ |
| BPS Change - H1, 2022 (O) - H1, 2021 | (-) 36 ↓ |
The comparative analysis and market growth rate of the global microneedle drug delivery systems market as studied by Future Market Insights shows a negative BPS growth in the H1-2022 outlook as compared to H1-2022 projected period by 50 BPS, and, a decline in the BPS growth is expected in H1-2022 over H1- 2021 duration with 36 basis point share (BPS).
The expensive costs of creating a reproducible microneedle patch as well as the high expenses of storing and packaging microneedles for safe distribution are also factors that have been cited as limiting the decline in BPS levels.
The market is expected to gain momentum towards expansion over the anticipated years thanks to the advantages of microneedles in advanced transdermal drug administration, including enhanced bioavailability of pharmaceuticals, reduced side effects, and rapid beginning of therapeutic action. The introduction of solid, dissolving, and coated microneedles for efficient transdermal drug administration is one of the market's major advances. With regard to medication safety and product licensing operations, the market for microneedle drug delivery systems is subject to changes based on regulatory and industry dynamics.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The Demand for Microneedles for Drug Delivery is Being Driven by an Increase in Cancer Patients
The demand for innovative and efficient drug delivery methods to enhance therapy is being driven by the rising prevalence of chronic diseases in the United States, including diabetes and cancer. As a result, businesses and research organizations are bringing new product development to the nation, establishing it as a profitable segment.
In 2022, the United States witnessed 1.9 million new cancer cases diagnosed and 609,360 cancer deaths, according to Cancer Facts & Figures (2022), an educational companion to Cancer Statistics (2022), an article published in the American Cancer Society journal. This is expected to encourage the development of new oncology treatments, driving the market for microneedle drug delivery systems in the country.
Demand for High-Quality Drugs & Access to Low-Cost Raw Ingredients Allows China to Expand its Industry
China is anticipated to hold a significant position in the East Asia market over the projection period. China's government organizations are investing more money in developing the healthcare industry, which is fostering the production of novel pharmaceuticals therein.
Several international pharmaceutical companies are looking to expand their operations in China due to the abundance of low-cost raw materials and the increased demand for generic medicines.
| Country | United States |
|---|---|
| CAGR (2018 to 2022) | 5.1% |
| CAGR (2023 to 2033) | 5.7% |
| Valuation (2033) | US$ 528.6 million |
| Country | United Kingdom |
|---|---|
| CAGR (2018 to 2022) | 6.4% |
| CAGR (2023 to 2033) | 7.0% |
| Valuation (2033) | US$ 84.4 million |
| Country | China |
|---|---|
| CAGR (2018 to 2022) | 5.7% |
| CAGR (2023 to 2033) | 6.2% |
| Valuation (2033) | US$ 77.1 million |
| Country | Germany |
|---|---|
| CAGR (2018 to 2022) | 4.7% |
| CAGR (2023 to 2033) | 5.1% |
| Valuation (2033) | US$ 79.3 million |
Solid Microneedles Dominate the Development of Microneedle Drug Delivery Devices
Solid microneedles remain the market leader despite a slight decline in market share during the anticipated time frame. They are anticipated to have covered more than 50% of the market by the end of 2033. In the meantime, hollow and dissolving microneedles are anticipated to proliferate more quickly with the usage of new technologies and uses.
Research on solid microneedles is now being conducted for several applications in an effort to increase their consistency, stability, and affordability. At the moment, research is concentrated on the creation of a microneedle array.
Hospitals Set to Account for Higher Consumption of Microneedles for Drug Delivery
In 2022, hospitals held a top position as end users, accounting for 44.1% of the global market. The expansion of the worldwide microneedle drug delivery systems market is anticipated to be aided by specialty clinics.
Specialty clinics held a 22% market share globally in 2022. As more clinics focus on particular disorders, the market potential is anticipated to rise in the future. For instance, one of the biggest consumers of microneedle drug delivery devices for procedures like hair restoration, facelifts, and wrinkle therapy are cosmetic clinics. Which is expected to eventually drive the microneedling for hair loss market.
The global microneedle drug delivery systems market is dominated by large- and medium-sized companies. However, it is led by a few important companies that, as part of their marketing strategy, are focusing on their market and value chain positions. Prominent market players use a range of tactics, such as early market entry, deep market penetration, as well as exclusive marketing and distribution licensing. Product innovation and differentiation, however, are essential market strategies for both mid-size and large businesses due to the diversity of market players.
Regardless of their size, companies use distribution rights acquisition and exclusive technology licensing as core strategies. In particular, a few businesses are focusing on strategic alliances in order to get a competitive edge.
Leading companies that sell microneedle drug delivery equipment are concentrating on Research and Development to introduce cutting-edge items in the market. In order to obtain a competitive edge in the market, firms are also engaging in mergers, acquisitions, and collaborations.
| Attribute | Details |
|---|---|
| Forecast Period | 2023 to 2033 |
| Historical Data Available for | 2018 to 2022 |
| Market Analysis | US$ million for Value |
| Key Regions Covered |
|
| Key Countries Covered |
|
| Key Market Segments Covered |
|
| Key Companies Profiled |
|
| Pricing | Available upon Request |
The market may register a revenue of US$ 768.9 million in 2023.
The United States is the leading country in the market.
China is the leading market and is expected to grow at 6.2% until 2033.
The solid microneedle segment dominates and could hold 50% of the global market by 2033.
The hospitals segment accounted the top position with 44.1% market share in 2022.
1. Executive Summary | Microneedle Drug Delivery Systems Market
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Investment Feasibility Matrix
3.5. PESTLE and Porter’s Analysis
3.6. Regulatory Landscape
3.6.1. By Key Regions
3.6.2. By Key Countries
3.7. Regional Parent Market Outlook
4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033
4.1. Historical Market Size Value (US$ Million) Analysis, 2018 to 2022
4.2. Current and Future Market Size Value (US$ Million) Projections, 2023 to 2033
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Product
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Million) Analysis By Product, 2018 to 2022
5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Product, 2023 to 2033
5.3.1. Solid Microneedles
5.3.1.1. Silicon
5.3.1.2. Metal
5.3.1.3. Polymer
5.3.2. Hollow Microneedles
5.3.3. Dissolving Microneedles
5.4. Y-o-Y Growth Trend Analysis By Product, 2018 to 2022
5.5. Absolute $ Opportunity Analysis By Product, 2023 to 2033
6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By End Use
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ Million) Analysis By End Use, 2018 to 2022
6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By End Use, 2023 to 2033
6.3.1. Hospitals
6.3.2. Ambulatory Surgical Centers
6.3.3. Specialty Clinics
6.3.4. Academic Institutions
6.3.5. Research Institutes
6.4. Y-o-Y Growth Trend Analysis By End Use, 2018 to 2022
6.5. Absolute $ Opportunity Analysis By End Use, 2023 to 2033
7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region
7.1. Introduction
7.2. Historical Market Size Value (US$ Million) Analysis By Region, 2018 to 2022
7.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2023 to 2033
7.3.1. North America
7.3.2. Latin America
7.3.3. Europe
7.3.4. South Asia
7.3.5. East Asia
7.3.6. Oceania
7.3.7. Middle East and Africa
7.4. Market Attractiveness Analysis By Region
8. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
8.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
8.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
8.2.1. By Country
8.2.1.1. USA
8.2.1.2. Canada
8.2.2. By Product
8.2.3. By End Use
8.3. Market Attractiveness Analysis
8.3.1. By Country
8.3.2. By Product
8.3.3. By End Use
8.4. Key Takeaways
9. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
9.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
9.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
9.2.1. By Country
9.2.1.1. Brazil
9.2.1.2. Mexico
9.2.1.3. Rest of Latin America
9.2.2. By Product
9.2.3. By End Use
9.3. Market Attractiveness Analysis
9.3.1. By Country
9.3.2. By Product
9.3.3. By End Use
9.4. Key Takeaways
10. Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
10.2.1. By Country
10.2.1.1. United Kingdom
10.2.1.2. Spain
10.2.1.3. Germany
10.2.1.4. Italy
10.2.1.5. France
10.2.1.6. Rest of Europe
10.2.2. By Product
10.2.3. By End Use
10.3. Market Attractiveness Analysis
10.3.1. By Country
10.3.2. By Product
10.3.3. By End Use
10.4. Key Takeaways
11. South Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
11.2.1. By Country
11.2.1.1. India
11.2.1.2. Malaysia
11.2.1.3. Indonesia
11.2.1.4. Thailand
11.2.1.5. Rest of South Asia
11.2.2. By Product
11.2.3. By End Use
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Product
11.3.3. By End Use
11.4. Key Takeaways
12. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
12.2.1. By Country
12.2.1.1. China
12.2.1.2. Japan
12.2.1.3. South Korea
12.2.2. By Product
12.2.3. By End Use
12.3. Market Attractiveness Analysis
12.3.1. By Country
12.3.2. By Product
12.3.3. By End Use
12.4. Key Takeaways
13. Oceania Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
13.2.1. By Country
13.2.1.1. Australia
13.2.1.2. New Zealand
13.2.2. By Product
13.2.3. By End Use
13.3. Market Attractiveness Analysis
13.3.1. By Country
13.3.2. By Product
13.3.3. By End Use
13.4. Key Takeaways
14. Middle East and Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
14.2.1. By Country
14.2.1.1. South Africa
14.2.1.2. GCC Countries
14.2.1.3. Rest of Middle East and Africa
14.2.2. By Product
14.2.3. By End Use
14.3. Market Attractiveness Analysis
14.3.1. By Country
14.3.2. By Product
14.3.3. By End Use
14.4. Key Takeaways
15. Key Countries Market Analysis
15.1. USA
15.1.1. Pricing Analysis
15.1.2. Market Share Analysis, 2022
15.1.2.1. By Product
15.1.2.2. By End Use
15.2. Canada
15.2.1. Pricing Analysis
15.2.2. Market Share Analysis, 2022
15.2.2.1. By Product
15.2.2.2. By End Use
15.3. Brazil
15.3.1. Pricing Analysis
15.3.2. Market Share Analysis, 2022
15.3.2.1. By Product
15.3.2.2. By End Use
15.4. Mexico
15.4.1. Pricing Analysis
15.4.2. Market Share Analysis, 2022
15.4.2.1. By Product
15.4.2.2. By End Use
15.5. United Kingdom
15.5.1. Pricing Analysis
15.5.2. Market Share Analysis, 2022
15.5.2.1. By Product
15.5.2.2. By End Use
15.6. Spain
15.6.1. Pricing Analysis
15.6.2. Market Share Analysis, 2022
15.6.2.1. By Product
15.6.2.2. By End Use
15.7. Germany
15.7.1. Pricing Analysis
15.7.2. Market Share Analysis, 2022
15.7.2.1. By Product
15.7.2.2. By End Use
15.8. Italy
15.8.1. Pricing Analysis
15.8.2. Market Share Analysis, 2022
15.8.2.1. By Product
15.8.2.2. By End Use
15.9. France
15.9.1. Pricing Analysis
15.9.2. Market Share Analysis, 2022
15.9.2.1. By Product
15.9.2.2. By End Use
15.10. India
15.10.1. Pricing Analysis
15.10.2. Market Share Analysis, 2022
15.10.2.1. By Product
15.10.2.2. By End Use
15.11. Malaysia
15.11.1. Pricing Analysis
15.11.2. Market Share Analysis, 2022
15.11.2.1. By Product
15.11.2.2. By End Use
15.12. Indonesia
15.12.1. Pricing Analysis
15.12.2. Market Share Analysis, 2022
15.12.2.1. By Product
15.12.2.2. By End Use
15.13. Thailand
15.13.1. Pricing Analysis
15.13.2. Market Share Analysis, 2022
15.13.2.1. By Product
15.13.2.2. By End Use
15.14. China
15.14.1. Pricing Analysis
15.14.2. Market Share Analysis, 2022
15.14.2.1. By Product
15.14.2.2. By End Use
15.15. Japan
15.15.1. Pricing Analysis
15.15.2. Market Share Analysis, 2022
15.15.2.1. By Product
15.15.2.2. By End Use
15.16. South Korea
15.16.1. Pricing Analysis
15.16.2. Market Share Analysis, 2022
15.16.2.1. By Product
15.16.2.2. By End Use
15.17. Australia
15.17.1. Pricing Analysis
15.17.2. Market Share Analysis, 2022
15.17.2.1. By Product
15.17.2.2. By End Use
15.18. New Zealand
15.18.1. Pricing Analysis
15.18.2. Market Share Analysis, 2022
15.18.2.1. By Product
15.18.2.2. By End Use
15.19. South Africa
15.19.1. Pricing Analysis
15.19.2. Market Share Analysis, 2022
15.19.2.1. By Product
15.19.2.2. By End Use
15.20. GCC Countries
15.20.1. Pricing Analysis
15.20.2. Market Share Analysis, 2022
15.20.2.1. By Product
15.20.2.2. By End Use
16. Market Structure Analysis
16.1. Competition Dashboard
16.2. Competition Benchmarking
16.3. Market Share Analysis of Top Players
16.3.1. By Regional
16.3.2. By Product
16.3.3. By End Use
17. Competition Analysis
17.1. Competition Deep Dive
17.1.1. 3M Company
17.1.1.1. Overview
17.1.1.2. Product Portfolio
17.1.1.3. Profitability by Market Segments
17.1.1.4. Sales Footprint
17.1.1.5. Strategy Overview
17.1.1.5.1. Marketing Strategy
17.1.2. Becton, Dickinson and Company
17.1.2.1. Overview
17.1.2.2. Product Portfolio
17.1.2.3. Profitability by Market Segments
17.1.2.4. Sales Footprint
17.1.2.5. Strategy Overview
17.1.2.5.1. Marketing Strategy
17.1.3. Zosano Pharma Corporation
17.1.3.1. Overview
17.1.3.2. Product Portfolio
17.1.3.3. Profitability by Market Segments
17.1.3.4. Sales Footprint
17.1.3.5. Strategy Overview
17.1.3.5.1. Marketing Strategy
17.1.4. RAPHAS Co., Ltd.
17.1.4.1. Overview
17.1.4.2. Product Portfolio
17.1.4.3. Profitability by Market Segments
17.1.4.4. Sales Footprint
17.1.4.5. Strategy Overview
17.1.4.5.1. Marketing Strategy
17.1.5. Nanopass Tech
17.1.5.1. Overview
17.1.5.2. Product Portfolio
17.1.5.3. Profitability by Market Segments
17.1.5.4. Sales Footprint
17.1.5.5. Strategy Overview
17.1.5.5.1. Marketing Strategy
17.1.6. Corium International, Inc.
17.1.6.1. Overview
17.1.6.2. Product Portfolio
17.1.6.3. Profitability by Market Segments
17.1.6.4. Sales Footprint
17.1.6.5. Strategy Overview
17.1.6.5.1. Marketing Strategy
17.1.7. Valeritas, Inc.
17.1.7.1. Overview
17.1.7.2. Product Portfolio
17.1.7.3. Profitability by Market Segments
17.1.7.4. Sales Footprint
17.1.7.5. Strategy Overview
17.1.7.5.1. Marketing Strategy
17.1.8. Nitto Denko Corporation
17.1.8.1. Overview
17.1.8.2. Product Portfolio
17.1.8.3. Profitability by Market Segments
17.1.8.4. Sales Footprint
17.1.8.5. Strategy Overview
17.1.8.5.1. Marketing Strategy
17.1.9. Microdermics, Inc.
17.1.9.1. Overview
17.1.9.2. Product Portfolio
17.1.9.3. Profitability by Market Segments
17.1.9.4. Sales Footprint
17.1.9.5. Strategy Overview
17.1.9.5.1. Marketing Strategy
17.1.10. TheraJect Inc.
17.1.10.1. Overview
17.1.10.2. Product Portfolio
17.1.10.3. Profitability by Market Segments
17.1.10.4. Sales Footprint
17.1.10.5. Strategy Overview
17.1.10.5.1. Marketing Strategy
17.1.11. Vaxxas Pty Ltd.
17.1.11.1. Overview
17.1.11.2. Product Portfolio
17.1.11.3. Profitability by Market Segments
17.1.11.4. Sales Footprint
17.1.11.5. Strategy Overview
17.1.11.5.1. Marketing Strategy
17.1.12. Endoderma Ltd.
17.1.12.1. Overview
17.1.12.2. Product Portfolio
17.1.12.3. Profitability by Market Segments
17.1.12.4. Sales Footprint
17.1.12.5. Strategy Overview
17.1.12.5.1. Marketing Strategy
17.1.13. QuadMedicine
17.1.13.1. Overview
17.1.13.2. Product Portfolio
17.1.13.3. Profitability by Market Segments
17.1.13.4. Sales Footprint
17.1.13.5. Strategy Overview
17.1.13.5.1. Marketing Strategy
17.1.14. SNvia Co., Ltd.
17.1.14.1. Overview
17.1.14.2. Product Portfolio
17.1.14.3. Profitability by Market Segments
17.1.14.4. Sales Footprint
17.1.14.5. Strategy Overview
17.1.14.5.1. Marketing Strategy
18. Assumptions & Acronyms Used
19. Research Methodology
Explore Healthcare Insights
View Reports
Microneedle Drug Delivery Systems Market
